Perspective Therapeutics Inc. (NYSE AMERICAN: CATX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT PERSPECTIVE THERAPEUTICS INC.

Perspective Therapeutics Inc. (NYSE AMERICAN: CATX)
Listen to this Section


$2.95
N/A ( 0% ) 0.0K

Perspective Therapeutics Inc is a medical technology and radiopharmaceutical company that is pioneering various treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha emitting isotope 212Pb to deliver powerful radiation specifically to cancer cells via specialized targeting peptides.

Market Data


Open $2.95
Previous Close $2.95
Volume 0.0K
Market Cap $336.44M
Day Range $3.02 - $3.02
52 Week Range $1.96 - $6.16
Shares Outstanding 114.05M
Change % 0%
Net Change N/A
Insider Ownership 0.01%
Exchange NYSE AMERICAN
SectorHealthcare
IndustryMedical/Dental Instruments
IPO Year2003
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 53,486,811.00

Date Type Amount Purchased Purchaser
2025-11-14 Buy 9498.00 Williamson Robert F III
2025-11-14 Buy 9498.00 Williamson Robert F III
2025-11-14 Buy 9498.00 Williamson Robert F III
2024-12-06 Buy 25975.00 HENSON HEIDI
2024-12-04 Buy 8000.00 Spoor Johan M.
2024-11-27 Buy 400.00 Hunt Jonathan Robert
2024-11-27 Buy 3647.00 Williamson Robert F III
2024-11-26 Buy 14500.00 Spoor Johan M.
2024-07-19 Sale -34500.00 Austin Mark John
2024-06-24 Sale -23000.00 Williamson Robert F III

SEC Filings


Form Type Description Pages Date
3 Insider transactions 2 Sep 05, 2025
8-k 8K-related 12 Sep 04, 2025
8-k 8K-related 12 Sep 03, 2025
8-k 8K-related 74 Sep 02, 2025
8-k 8K-related 77 Aug 13, 2025
10-q Quarterly Reports 67 Aug 13, 2025
8-k 8K-related 75 Aug 01, 2025
8-k 8K-related 74 Jul 03, 2025
8-k 8K-related 80 Jun 23, 2025
8-k 8K-related 74 Jun 03, 2025

Latest News


× Before browsing our site, please accept our cookies policy